Tag: abemaciclib

Abemaciclib FDA approval : Lilly breast cancer drug gets regulatory nod

pharmanewsdaily- September 30, 2017

Abemaciclib FDA approval : Eli Lilly and Company (Lilly) has secured the US FDA approval for Verzenio (abemaciclib) to treat metastatic breast cancer in patients ... Read More

Lilly’s breast cancer drug abemaciclib meets objective in phase 3 trial

pharmanewsdaily- March 22, 2017

Indianapolis-based Lilly has reported that its breast cancer drug, abemaciclib, in combination with fulvestrant, has yielded positive results by meeting its primary endpoint, progression-free survival ... Read More